March 11, 2016 Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (Including Biological Products) in Neonates Ward RM, Benjamin D, Barrett JS, Allegaert K, Portman R, Davis JM, Turner MA, and the International Neonatal Consortium. Safety, D
July 8, 2015 Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates Offringa M, Davis JM, Turner MA, Ward R, Bax R, Maldonado S, Sinha V, McCune SK, Zajicek A, Daniel K. Benjamin J, Bucci-Rechtweg C
January 10, 2015 Global Collaboration to Develop New and Existing Drugs for Neonates Davis JM, Turner MA. Global Collaboration to Develop New and Existing Drugs for Neonates. JAMA pediatrics. 2015 Oct;169(10):887–
January 12, 2014 Regulatory Science Needs for Neonates: A Call for Neonatal Community Collaboration and Innovation
March 19, 2024 The International Neonatal Consortium: Collaborating to Advance Regulatory Science for Neonates Turner MA, Davis JM, McCune S, Bax R, Portman RJ, Hudson, LD. “The International Neonatal Consortium Collaborating to Adv
March 19, 2024 Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development
March 19, 2024 Global Efforts to Accelerate the Development of Safe and Efficacious Therapies for Newborns